Show Search Form

Search Results

registered interest	true false
date	exactly: or between: and
answering body
answering dept id
answering dept short name
answering dept sort name
hansard heading
house id
legislature	pref label
question text
tabling member constituency
tabling member printed
uin
answer	is ministerial correction true false date of answer exactly: or between: and answer text answering member constituency answering member printed question first answered answering member label previous answer version answering member constituency answering member printed answering member label
tabling member	label

Search

1655803

registered interest
date	01/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination: Manufacturing Industries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to A review of the Vaccine Taskforce, published by his Department on 29 August 2023, what additional vaccine production capacity, of any type, has been secured as a result of the investments made (a) by the Vaccine Taskforce and (b) subsequently by the Office for Life Sciences, as described in the report.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	195638
answer	answer is ministerial correction date of answer 08/09/2023 answer text <p>Through the Vaccine Taskforce, over £405 million was invested in the United Kingdom’s vaccine manufacturing capabilities across several modalities, to ensure a robust response to COVID-19 and future health emergencies. In December 2022 the Government signed a ten-year strategic partnership with Moderna which will have the capacity to produce up to 250 million cutting-edge mRNA vaccines per year onshore in the event of a pandemic. In May this year, the Government announced a Biomanufacturing Fund, worth up to £38 million, to incentivise investment in commercial-scale vaccines and biotherapeutics manufacturing.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 08/09/2023 14:12:09 answering member 4492 label Biography information for Maria Caulfield
tabling member	318 label Biography information for John Spellar

1655804

registered interest
date	01/09/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Vaccination: Manufacturing Industries
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to his Department’s paper A review of the Vaccine Taskforce, published on 29 August 2023, what funds the Office for Life Sciences has to invest in additional vaccine production capacity in the UK in order to achieve the onshoring programme objective set for the Vaccines Taskforce.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	195639
answer	answer is ministerial correction date of answer 08/09/2023 answer text <p>Through the Vaccine Taskforce, over £405 million was invested in the United Kingdom’s vaccine manufacturing capabilities across several modalities, to ensure a robust response to COVID-19 and future health emergencies. In December 2022 the Government signed a ten-year strategic partnership with Moderna which will have the capacity to produce up to 250 million cutting-edge mRNA vaccines per year onshore in the event of a pandemic. In May this year, the Government announced a Biomanufacturing Fund, worth up to £38 million, to incentivise investment in commercial-scale vaccines and biotherapeutics manufacturing.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 08/09/2023 14:13:16 answering member 4492 label Biography information for Maria Caulfield
tabling member	318 label Biography information for John Spellar

1625243

registered interest
date	02/05/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Human Papillomavirus: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, what steps his Department is taking to increase the HPV vaccination rate.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	183309
answer	answer is ministerial correction date of answer 09/05/2023 answer text <p>The human papillomavirus (HPV) vaccination programme is delivered in different locations to maximise access and make getting vaccinated easier. This includes school-based delivery, with alternative sites set up for those not in mainstream education, or for those who missed their initial offer. HPV vaccinations are also offered to men who have sex with men aged up to and including 45-year-olds, through Specialist Sexual Health Services and/or HIV clinics. General practices (GPs) also offer HPV catch-up vaccinations for anyone eligible, until their 25th birthday.</p><p>Additionally, the Department, NHS England and the UK Health Security Agency deliver communication campaigns across GPs and universities to encourage people to get vaccinated. It is vitally important that everyone takes up the vaccinations to which they are entitled, for themselves, their families and wider society. Anyone unsure about their eligibility or vaccination status should contact their GP for advice.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 09/05/2023 12:50:21 answering member 4492 label Biography information for Maria Caulfield
tabling member	318 label Biography information for John Spellar

1604014

registered interest
date	14/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 10 March 2023 on Question 158778, for what reason the service specification for the school aged flu immunisation programme is not published; and if he will consider the potential merits of publishing this information.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	165198
answer	answer is ministerial correction date of answer 21/03/2023 answer text <p>The School Aged Immunisation Service (SAIS) specification covers all school age immunisations, including flu. It is a template for NHS England regional commissioners to commission SAIS providers that evolves in line with latest policy advice, for example, the addition of flu cohorts. Contracts are held between NHS England regions and SAIS providers and are varied to best meet local need. It is on these grounds NHS England does not publish the specification. This is in contrast to the general practitioner and community pharmacy flu service specifications, which are published as they are part of a national contract. However, each year the annual flu letter is published by the UK Health Security Agency and outlines which groups are eligible for a free vaccine as part of the National Health Service programme, including children.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 21/03/2023 15:21:23 answering member 4492 label Biography information for Maria Caulfield
tabling member	318 label Biography information for John Spellar

1601371

registered interest
date	06/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, with reference to the paper by the Joint Committee on Vaccinations and Immunisation, entitled Advice on influenza vaccines for 2023-24, published on 30 November 2022, whether it is his policy to take steps in line with the advice of the Joint Committee that flu vaccinations for secondary school children should be routine.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	158776
answer	answer is ministerial correction date of answer 13/03/2023 answer text <p>The Joint Committee on Vaccination and Immunisation published advice on 30 November 2022 regarding the 2023/24 seasonal flu vaccination programme. The Government is considering this advice and details about which cohorts will be offered a free seasonal flu vaccine in England in 2023/24, and which vaccines they will be offered, will be set out in due course.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 13/03/2023 10:33:16 answering member 4492 label Biography information for Maria Caulfield previous answer version 61025 answering member constituency Lewes answering member printed Maria Caulfield answering member 4492 label Biography information for Maria Caulfield
tabling member	318 label Biography information for John Spellar

1601372

registered interest
date	06/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether his Department has made an assessment of the impact on (a) uptake of vaccinations among eligible cohorts and (b) number of childhood influenza cases over the 2021-22 flu season in the context of the vaccine delivery completion deadline for the Childhood Influenza Vaccination Programme for 2021-22 moving from 15 December 2021 to the end of January 2022.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	158777
answer	answer is ministerial correction date of answer 09/03/2023 answer text <p>Overall low levels of influenza activity were seen in 2021 to 2022, with late season activity peaking in week 12 and week 14 of 2022, weeks beginning 20 March and 3 April, when hospital and critical care admissions peaked but at lower levels than seen in previous seasons. The UK Health Security Agency (UKHSA) weekly surveillance reports is available at the following link:</p><p>www.gov.uk/government/statistics/national-flu-and-covid-19-surveillance-reports-2021-to-2022-season</p><p>The UKHSA monthly influenza vaccine uptake data shows that the majority of children were vaccinated by end of December 2021 available at the following link:</p><p>www.gov.uk/government/statistics/seasonal-flu-vaccine-uptake-in-children-of-school-age-monthly-data-2021-to-2022</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 09/03/2023 12:42:10 answering member 4492 label Biography information for Maria Caulfield
tabling member	318 label Biography information for John Spellar

1601374

registered interest
date	06/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, whether NHS England plans to publish the service specification for childhood influenza vaccination as part of School Aged Immunisation Service activity for 2023-24.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	158778
answer	answer is ministerial correction date of answer 10/03/2023 answer text <p>Ahead of each flu season NHS England confirms the requirements for the seasonal flu programme with all relevant contracted providers. The service specification for the school aged flu immunisation programme is not published in the public domain.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 10/03/2023 10:40:58 answering member 4492 label Biography information for Maria Caulfield
tabling member	318 label Biography information for John Spellar

1601379

registered interest
date	06/03/2023
answering body	Department of Health and Social Care
answering dept id	17
answering dept short name	Health and Social Care
answering dept sort name	Health and Social Care
hansard heading	Influenza: Vaccination
house id	1
legislature	25259 pref label House of Commons
question text	To ask the Secretary of State for Health and Social Care, pursuant to the Answer of 3 March 2023 to Question 151418 on Influenza: Vaccination, for what reason the disclosure of the quantity of flu vaccinations is considered commercially sensitive.
tabling member constituency	Warley
tabling member printed	John Spellar
uin	158779
answer	answer is ministerial correction date of answer 09/03/2023 answer text <p>The volume of flu vaccines procured by UK Health Security Agency test is commercially sensitive as it could potentially be used to determine the cost per unit of vaccines. The release of this information would therefore be detrimental in future negotiations with individual suppliers.</p> answering member constituency Lewes answering member printed Maria Caulfield question first answered 09/03/2023 12:57:35 answering member 4492 label Biography information for Maria Caulfield
tabling member	318 label Biography information for John Spellar